PL313116A1 - Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs - Google Patents

Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs

Info

Publication number
PL313116A1
PL313116A1 PL94313116A PL31311694A PL313116A1 PL 313116 A1 PL313116 A1 PL 313116A1 PL 94313116 A PL94313116 A PL 94313116A PL 31311694 A PL31311694 A PL 31311694A PL 313116 A1 PL313116 A1 PL 313116A1
Authority
PL
Poland
Prior art keywords
dihydropridinocarboxylic
alkalated
drugs
esters
application
Prior art date
Application number
PL94313116A
Other languages
English (en)
Inventor
Siegfried Zaiss
Dieter Neuser
Johannes-Peter Stasch
Siegfried Goldmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL313116A1 publication Critical patent/PL313116A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL94313116A 1993-08-27 1994-08-16 Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs PL313116A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4328884A DE4328884A1 (de) 1993-08-27 1993-08-27 Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
PCT/EP1994/002723 WO1995005823A1 (de) 1993-08-27 1994-08-16 Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsäureestern als arzneimittel

Publications (1)

Publication Number Publication Date
PL313116A1 true PL313116A1 (en) 1996-06-10

Family

ID=6496196

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94313116A PL313116A1 (en) 1993-08-27 1994-08-16 Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs

Country Status (13)

Country Link
EP (1) EP0714301A1 (de)
JP (1) JPH09501923A (de)
KR (1) KR960703594A (de)
CN (1) CN1129906A (de)
AU (1) AU7613594A (de)
BG (1) BG100367A (de)
CA (1) CA2170285A1 (de)
CZ (1) CZ43896A3 (de)
DE (1) DE4328884A1 (de)
HU (1) HUT75302A (de)
NO (1) NO960777L (de)
PL (1) PL313116A1 (de)
WO (1) WO1995005823A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741694C2 (de) * 1997-09-18 2002-10-31 Schering Ag Verwendung von Komplexen, deren Ligand ein Bis-Amin-Oxim-Derivat oder ein N¶2¶S¶2¶-Derivat und deren Zentralatom ein Radionuklid ist
EP1458682B1 (de) * 2001-12-20 2006-08-30 Bayer HealthCare AG 1, 4-dihydro-1, 4-diphenylpyridin-derivate
CA2854252C (en) * 2011-11-24 2016-11-29 Lipidart Kutato Fejleszto Es Tanacsado Kft. 1,4-dihydropyridine derivatives with hsp modulating activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
EP0169009A3 (de) * 1984-07-17 1988-08-31 FISONS plc Dihydropyridinderivate und ihre Herstellung, Formulierung und Verwendung als Pharmazeutika
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2170285A1 (en) 1995-03-02
DE4328884A1 (de) 1995-03-02
CN1129906A (zh) 1996-08-28
AU7613594A (en) 1995-03-21
HUT75302A (en) 1997-05-28
JPH09501923A (ja) 1997-02-25
EP0714301A1 (de) 1996-06-05
WO1995005823A1 (de) 1995-03-02
HU9600472D0 (en) 1996-04-29
CZ43896A3 (en) 1996-05-15
BG100367A (en) 1996-07-31
NO960777D0 (no) 1996-02-26
KR960703594A (ko) 1996-08-31
NO960777L (no) 1996-04-10

Similar Documents

Publication Publication Date Title
HU9402974D0 (en) Pharmaceutical composition
AU3888793A (en) Novel medicament
ZA946262B (en) Pharmaceutical compositions
AU3720193A (en) Hydroisoindolines and hydroisoquinolines as psychotropic drugs
GB9317610D0 (en) Pharmaceutical compositions
ZA945930B (en) Pharmaceutical composition
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
GB9303538D0 (en) Medicament presentation
PL314036A1 (en) Pharmaceutical composition
ZA941163B (en) Medicament presentation
CA2100836A1 (en) Pharmaceutical composition
GB9317504D0 (en) Pharmaceutical compositions
ZA945752B (en) Pharmaceutical composition
PL313116A1 (en) Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs
PL310146A1 (en) Application of 1,4-dihydropyridino-3,5-dicarboxylic esters as drugs as well as novel active substances and drugs
GB9318880D0 (en) Pharmaceutical composition
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
HU9401771D0 (en) Pharmaceutical compositions cintaining ipsapiron
AU3528593A (en) Pharmaceutical composition
SG47980A1 (en) Pharmaceutical compositions
AU5239493A (en) Methods for administration of taxol
GB9318350D0 (en) Pharmaceutical composition
ZA947913B (en) Pharmaceutical composition
ZA935269B (en) Pharmaceutical composition
HU9303511D0 (en) Pharmaceutical composition